IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: Results from the Shanghai Breast Cancer Study

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 1, 2008, Pages 255-257

  Deming, Sandra L ^a   Ren, Zefang ^a,c   Cai, Qiuyin ^a   Shu, Xiao Ou ^a   Wen, Wanqing ^a   Long, Ji Rong ^a   Gao, Yu Tang ^b   Zheng, Wei ^a,d  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 38849161379     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2588     Document Type: Article

References (16)

1. Deeks S, Richards J, Nandi S. Maintenance of normal rat mammary epithelial cells by insulin and insulin-like growth factor 1. Exp Cell Res 1988;174:448-60.
2. Shamay A, Cohen N, Niwa M, Gertler A. Effect of insulin-like growth factor I on deoxyribonucleic acid synthesis and galactopoiesis in bovine undifferentiated and lactating mammary tissue in vitro. Endocrinology 1988;123:804-9.
3. Pacher M, Seewald MJ, Mikula M, et al. Impact of constitutive IGF-I/IGF-II stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis 2007;28:49-59.
4. Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF-I and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF-I, IGFBP3 and risk of breast cancer. Hum Mol Genet 2006;15:1-10.
5. Setiawan VW, Cheng I, Stram DO, et al. Igf-I genetic variation and breast cancer: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006;15:172-4.
6. Canzian F, McKay JD, Cleveland RJ, et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 2006;94:299-307.
7. DeLellis K, Ingles S, Kolonel L, et al. IGF-I genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 2003;88:277-82.
8. Missmer SA, Haiman CA, Hunter DJ, et al. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 2002;100:332-6.
9. Wen W, Gao YT, Shu XO, et al. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer 2005;113:307-11.
10. Cleveland RJ, Gammon MD, Edmiston SN, et al. IGF-I CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 2006;27:758-65.
11. Yu H, Li BD, Smith M, Shi R, Berkel HJ, Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 2001;70:117-22.
12. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
13. Zheng W, Gao YT, Shu XO, et al. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:709-14.
14. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
15. Lin DY, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 2005;29:299-312.
16. Gauderman W. Sample size requirement for case-control studies of gene environment interaction. Stat Med 2002;21:35-50.